2m 2m 2m 2m 2m 2m 2m
CAPRICOR THERAP (CAPR)
NASDAQ
$6.39+$0.10 (+1.59%)
Price as of Aug 21, 2026 7:59 PM EDT- $365.7MMarket Cap
- -11.41%1-Year Change
- BiotechnologyIndustry
CAPRICOR THERAP (CAPR)
$6.39+$0.10 (+1.59%)
CAPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.29 | ||
Change | -$0.54 (-7.97%) | ||
Open | $6.81 | ||
High | $7.08 | ||
Low | $6.01 | ||
Previous Close | $6.83 | ||
Volume | 8,360,730 | ||
30-Day Average Volume | 11,541,495 | ||
1-Week Change | -5.41% | ||
1-Month Change | -68.22% | ||
1-Year Change | -11.41% | ||
3-Year Change | -18.42% | ||
5-Year Change | 62.53% | ||
Fundamentals | |||
Shares Outstanding | 58.1M | ||
Total Assets | $368.7M | ||
Market Cap | $365.7M | ||
Enterprise Value | $344.8M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$40.7M | ||
Free Cash Flow | -$35.5M | ||
EBIT | -$40.7M | ||
EBITDA | -$40.2M | ||
Net Working Capital | $209.2M | ||
EPS | -$0.70 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -9 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/05/2019 | ||
Earnings & Revenue